Open AccessPurine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes
Author(s) -
Filip Ottosson,
Einar Smith,
Widet Gallo,
Céline Fernandez,
Olle Melander
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2019-00822
Subject(s) - metabolomics , metabolite , type 2 diabetes , context (archaeology) , prospective cohort study , cohort , medicine , diabetes mellitus , cohort study , population , type 2 diabetes mellitus , metabolome , endocrinology , bioinformatics , biology , environmental health , paleontology
Metabolomics has the potential to generate biomarkers that can facilitate understanding relevant pathways in the pathophysiology of type 2 diabetes (T2DM).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom